S12 Ep17: Midweek Takeaway with Anthony Tennyson, CEO of Solvonis Therapeutics plc (LSE: SVNS) #SVNS
In this episode of the Midweek Takeaway, Phil Carroll and Kevin Hornsby welcome Anthony Tennyson from Solvonis Therapeutics (#SVNS) to discuss the latest US patent developments covering ketamine-based treatments for behavioural addictions.
The conversation explores potential licensing opportunities, commercial partnerships, ongoing clinical programmes, regulatory progress and upcoming milestones as the company continues to expand its treatment portfolio.
Disclaimer & Declaration of Interest
This podcast may contain paid promotions, including but not limited to sponsorships, endorsements, or…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.